{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:33:05Z","timestamp":1794346385012,"version":"4.9.0"},"publisher-location":"Vienna","reference-count":33,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211330784","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-3-211-33079-1_28","type":"book-chapter","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T21:56:12Z","timestamp":1180216572000},"page":"205-211","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome"],"prefix":"10.1007","author":[{"given":"Johan S.","family":"Rietman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H. B.","family":"Geertzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"28_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3171\/jns.2003.98.2.0291","volume":"98","author":"A.L. Allbright","year":"2003","unstructured":"Allbright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF (2003) Long-term intrathecal baclofen therapy for severe spasticity of cerebellar origin. J Neurosurg 98(2): 291\u2013295","journal-title":"J Neurosurg"},{"key":"28_CR2","first-page":"540","volume":"192","author":"B. Ashworth","year":"1964","unstructured":"Ashworth B (1964) Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192: 540\u2013542","journal-title":"Practitioner"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0003-9993(96)90217-8","volume":"77","author":"P. Azouvi","year":"1996","unstructured":"Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 77: 35\u201339","journal-title":"Arch Phys Med Rehabil"},{"key":"28_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s004150050067","volume":"244","author":"R. Becker","year":"1997","unstructured":"Becker R, Alberti O, Bauer BL (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 244: 160\u2013166","journal-title":"J Neurol"},{"issue":"4","key":"28_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.clineuro.2004.09.007","volume":"107","author":"E.J. Boviatsis","year":"2005","unstructured":"Boviatsis EJ, Kouyialis AT, Korfias, Sakas DE (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107(4): 289\u2013295","journal-title":"Clin Neurol Neurosurg"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/ptj\/67.4.522","volume":"67","author":"R.W. Bohannon","year":"1987","unstructured":"Bohannon RW, Smith MB (1987) Assessment of strength deficits in eight paretic upper extremity muscle groups of stroke patients with hemiplegia. Phys Ther 67: 522\u2013555","journal-title":"Phys Ther"},{"issue":"4","key":"28_CR7","first-page":"227","volume":"19","author":"P. Bramanti","year":"2004","unstructured":"Bramanti P, D\u2019Aleo G, Rifici C, Alagna A, Cannata A, Sessa E et al (2004) Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales. Funct Neurol 19(4): 227\u2013231","journal-title":"Funct Neurol"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","volume":"78","author":"J.R. Coffey","year":"1993","unstructured":"Coffey JR, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B et al (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78: 226\u2013232","journal-title":"J Neurosurg"},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1034\/j.1600-0404.2002.1o042.x","volume":"105","author":"A. Dario","year":"2002","unstructured":"Dario A, Di Stefano MG, Grossi A, Casagrande F, Bono G (2002) Long-term intrathecal baclofen infusion in supraspinal spasticity of adulthood. Act Neurol Scand 105: 83\u201387","journal-title":"Act Neurol Scand"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0003-9993(03)00134-5","volume":"84","author":"G.E. Francisco","year":"2003","unstructured":"Francisco GE, Boake C (2003) Improvement in walking speed in post-stroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch Phys Med Rehab 84: 194\u2013199","journal-title":"Arch Phys Med Rehab"},{"issue":"5","key":"28_CR11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/02699050400003999","volume":"19","author":"G.E. Francisco","year":"2005","unstructured":"Francisco GE, Hu MM, Boake C, Ivanhoe CB (2005) Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj 19(5): 359\u2013364","journal-title":"Brain Inj"},{"key":"28_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01376517-199802000-00006","volume":"30","author":"J.M. Gianino","year":"1998","unstructured":"Gianino JM, York MM, Paice JA, Shott S (1998) Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 30: 47\u201354","journal-title":"J Neurosci Nurs"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307380001500201","volume":"15","author":"R. Gilmartin","year":"2000","unstructured":"Gilmartin R, Bruce D, Storrs B, Abbott R, Krach L, Ward J et al (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15: 71\u201377","journal-title":"J Child Neurol"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.apmr.2004.11.013","volume":"86","author":"T.S. Horn","year":"2005","unstructured":"Horn TS, Yablon SA, Stokic DS (2005) Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehab 86: 1127\u20131133","journal-title":"Arch Phys Med Rehab"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S0317167100042244","volume":"19","author":"H. Hugenholtz","year":"1992","unstructured":"Hugenholtz H, Nelson RF, Dehoux E, Bickerton R (1992) Intrathecal baclofen for intractable spinal spasticity \u2014 a double-blind crossover comparison with placebo in 6 patients. Can J Neurol Sc 19: 188\u2013195","journal-title":"Can J Neurol Sc"},{"issue":"12","key":"28_CR16","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1114\/1.1424918","volume":"29","author":"D.G. Kamper","year":"2001","unstructured":"Kamper DG, Schmitt BD, Rymer WZ (2001) Effect of muscle biomechanics on the quantification of spasticity. Ann Biomed Eng 29(12): 1122\u20131134","journal-title":"Ann Biomed Eng"},{"issue":"3","key":"28_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13638490400021479","volume":"8","author":"L.E. Krach","year":"2005","unstructured":"Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R et al (2005) GMFM 1 year after continuous intrathecal baclofen infusion. Pediat Rehab 8(3): 207\u2013213","journal-title":"Pediat Rehab"},{"key":"28_CR18","first-page":"485","volume-title":"Spasticity: disordered motor control","author":"J.W. Lance","year":"1980","unstructured":"Lance JW (1980) Symposium synopsis. In: Feldman RG, Young RR, Koella WP (eds) Spasticity: disordered motor control. Year Book Medical Publishers, Chicago, pp 485\u2013494"},{"key":"28_CR19","first-page":"48","volume":"29","author":"P.G. Loubser","year":"1991","unstructured":"Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russel KD (1991) Continuous infusion of intrathecal baclofen. Long term effects on spasticity in spinal cord injury. Paraplegia 29: 48\u201364","journal-title":"Paraplegia"},{"key":"28_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00002060-199212000-00003","volume":"71","author":"J.M. Meythaler","year":"1992","unstructured":"Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS (1992) Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 71: 321\u2013327","journal-title":"Am J Phys Med Rehabil"},{"key":"28_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0003-9993(99)90301-5","volume":"80","author":"J.M. Meythaler","year":"1999","unstructured":"Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN (1999) Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1 year experience. Arch Phys Med Rehab 80: 13\u201319","journal-title":"Arch Phys Med Rehab"},{"key":"28_CR22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/hs0901.095682","volume":"32","author":"J.M. Methaler","year":"2002","unstructured":"Methaler JM, Guin-Renfroe S, Brunner RC (2002) Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32: 2099\u20132109","journal-title":"Stroke"},{"key":"28_CR23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.63.2.204","volume":"63","author":"B. Middel","year":"1997","unstructured":"Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, Terpstra S, Stewart R (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63: 204\u2013209","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"28_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/BF00314294","volume":"234","author":"H. M\u00fcller","year":"1987","unstructured":"M\u00fcller H, Zierski J, Dralle D et al (1987) The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 234: 348\u2013352","journal-title":"J Neurol"},{"key":"28_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3171\/jns.1996.85.3.0452","volume":"85","author":"J.I. Ordia","year":"1996","unstructured":"Ordia JI, Fischer E, Adamski E, Spatz EL (1996) Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 85: 452\u2013457","journal-title":"J Neurosurg"},{"key":"28_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(85)90228-4","volume":"2","author":"R.D. Penn","year":"1985","unstructured":"Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2: 125\u2013127","journal-title":"Lancet"},{"key":"28_CR27","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","volume":"320","author":"R.D. Penn","year":"1989","unstructured":"Penn RD, Savoy SM, Corcoc D, Latash M, Gottlieb G, Parke B, Kroin JS (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320: 1517\u20131521","journal-title":"N Engl J Med"},{"key":"28_CR28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3171\/jns.1992.77.2.0236","volume":"77","author":"R.D. Penn","year":"1992","unstructured":"Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77: 236\u2013240","journal-title":"J Neurosurg"},{"key":"28_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/sj.sc.3101647","volume":"42","author":"R. Plassat","year":"2004","unstructured":"Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Math\u00e9 JF, Richard I (2004) Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42: 686\u2013693","journal-title":"Spinal Cord"},{"key":"28_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3171\/jns.1999.91.5.0733","volume":"91","author":"B. Rawicki","year":"1999","unstructured":"Rawicki B (1999) Treatment of cerebral origin spasticity with continuous baclofen delivered via an implantable pump: long-term follow-up review of 18 patients. J Neurosurg 91: 733\u2013736","journal-title":"J Neurosurg"},{"key":"28_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0003-9993(02)04906-7","volume":"84","author":"O. R\u00e9my-N\u00e9ris","year":"2003","unstructured":"R\u00e9my-N\u00e9ris O, Tiffreau V, Bouilland S, Bussel B (2003) Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch Phys Med Rehab 84: 643\u2013650","journal-title":"Arch Phys Med Rehab"},{"key":"28_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00002060-200011000-00010","volume":"79","author":"L. Stempien","year":"2000","unstructured":"Stempien L, Tsai T (2000) Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehab 79: 536\u2013541","journal-title":"Am J Phys Med Rehab"},{"key":"28_CR33","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/jnnp.2003.014282","volume":"75","author":"A. Zahavi","year":"2004","unstructured":"Zahavi A, Geertzen JHB, Middel B, Staal M, Rietman JS (2004) Long term effect (more than five years) of intrathecal baclofen on impairment, disability and quality of live in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psych 75: 1553\u20131557","journal-title":"J Neurol Neurosurg Psych"}],"container-title":["Acta Neurochirurgica Supplements","Operative Neuromodulation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-211-33079-1_28.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T11:21:32Z","timestamp":1607599292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-211-33079-1_28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783211330784"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-3-211-33079-1_28","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-211-33079-1","asserted-by":"object"}]},"subject":[]}}